# Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

> **NCT04301089** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 61 (actual)

## Conditions studied

- Anxiety

## Interventions

- **DEVICE:** Pico G2 4K Headset with Applied VR software
- **OTHER:** Patient Reported Questionnaires
- **BIOLOGICAL:** Saliva sample collection (hormones)

## Key facts

- **NCT ID:** NCT04301089
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-18
- **Primary completion:** 2025-02-04
- **Final completion:** 2025-02-04
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04301089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04301089, "Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04301089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*